` 0O5H (Elekta AB (publ)) vs OMX Stockholm 30 Comparison - Alpha Spread

0O5H
vs
O
OMX Stockholm 30

Over the past 12 months, 0O5H has underperformed OMX Stockholm 30, delivering a return of +16% compared to the OMX Stockholm 30's +33% growth.

Stocks Performance
0O5H vs OMX Stockholm 30

Loading
0O5H
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
0O5H vs OMX Stockholm 30

Loading
0O5H
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
0O5H vs OMX Stockholm 30

Loading
0O5H
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Elekta AB (publ) vs Peers

OMX Stockholm 30
0O5H
LEG
PMT
DFS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Elekta AB (publ)
Glance View

Market Cap
21.2B SEK
Industry
Health Care

Elekta AB emanates sophistication and precision, standing at the forefront of medical technology. Established in 1972 by Lars Leksell, the Swedish innovator manifests a legacy deeply rooted in advancing oncology and neurosurgery treatment solutions. Elekta's forte lies in crafting state-of-the-art equipment and software that assist medical practitioners in treating complex cancers and brain disorders. Their products, such as the Leksell Gamma Knife and various advanced linear accelerators, showcase their commitment to minimally invasive treatment. By developing cutting-edge systems that refine radiation therapy and radio-surgery, Elekta plays a pivotal role in enhancing patient outcomes, offering more precise targeting of tumors with minimal damage to surrounding healthy tissues. Financially, Elekta thrives through a multi-faceted revenue model that harmoniously blends hardware sales with recurring income from maintenance services, software upgrades, and training. Their business strategy capitalizes on long-term relationships with healthcare providers, ensuring a steady demand for both product innovation and servicing their existing installations. By anchoring its revenue stream in this hybrid fashion, Elekta offers a compelling proposition for shareholders—a blend of resilient cash flow dynamics and growth through groundbreaking technological advancements. As the global healthcare landscape evolves, Elekta's continuous investment in research and development ensures they remain a venerated leader in tackling the world's challenges in cancer care and neurological disorders.

0O5H Intrinsic Value
82.519 SEK
Undervaluation 33%
Intrinsic Value
Price kr55.525
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett